PW-003 - COST EFFECTIVENESS (CE) OF PHARMACOGENETIC (PGX) TESTING FOR DRUGS WITH CLINICAL PHARMACOGENETICS IMPLEMENTATION CONSORTIUM (CPIC) GUIDELINES: A SYSTEMATIC REVIEW.

J. Patel¹, S. Morris¹, A. Alsaidi², A. Cruz¹, A. Verbyla¹, C. Macfarlane², J. Bauer¹; ¹Levine Cancer Institute, Atrium Health, Charlotte, NC, USA, ²Wingate University, Wingate, NC, USA.

Presenting Author(s)

Jai N. Patel, PharmD

Chair, Cancer Pharmacology and Pharmacogenomics
Levine Cancer Institute, Atrium Health
Charlotte, North Carolina, United States